Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972 Free

Abstract

Venezuelan equine encephalitis (VEE) virus is a mosquito-borne pathogen that has caused encephalitis in equine species and humans during sporadic outbreaks in the western hemisphere. The last, and most widespread, VEE outbreak occurred in South America, Central America, Mexico and the U.S.A. (Texas) during 1969 to 1972. We have cloned and sequenced the genome of a virulent VEE subtype I-AB virus, strain 71-180, isolated in Texas in 1971. Thirty-four nucleotide differences were detected between the genome of 71-180 virus and that of the subtype I-AB Trinidad donkey (TRD) virus isolated during the 1943 VEE epizootic in Trinidad. Fifteen nucleotide changes occurred in the non-structural genes, 16 in the structural genes and three in the 3′ non-coding region. Only six of the nucleotide differences resulted in amino acid substitutions: one change in each of non-structural proteins nsP1 and nsP3, two in the E2 envelope glycoprotein, one in the 6K polypeptide and one in the E1 envelope glycoprotein. The close genetic relationship between 71-180 virus and TRD virus, commonly used for production of formalin-inactivated VEE vaccines, suggests that incompletely inactivated virulent vaccine virus may have been the source of this and other VEE outbreaks. Use of formalized virulent virus was discontinued during the 1969 to 1972 panzootic. No VEE epizootics have been reported since the introduction of the live attenuated TC-83 vaccine virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-12-3301
1992-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/12/JV0730123301.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-12-3301&mimeType=html&fmt=ahah

References

  1. Beck C. E., Wyckoff R. W. G. 1938; Venezuelan encephalitis. Science 88:530
    [Google Scholar]
  2. Berge T. O., Banks I. S., Tigertt W. D. 1961; Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea-pig heart cells. American Journal of Hygiene 73:209–218
    [Google Scholar]
  3. Calisher C. H., Kinney R. M., de Souza Lopez O., Trent D. W., Monath T. P., Francy D. B. 1982; Identification of a new Venezuelan equine encephalitis virus from Brazil. American Journal of Tropical Medicine and Hygiene 31:1260–1272
    [Google Scholar]
  4. Calisher C. H., Monath T. P., Mitchell C. J., Sabattini M. S., Cropp C. B., Kerschner J., Hunt A. R., Lazuick J. S. 1985; Arbovirus investigations in Argentina, 1977–1980. III. Identification and characterization of viruses isolated, including new subtypes of western and Venezuelan equine encephalitis viruses and four new bunyaviruses (Las Malayos, Resistencia, Barranqueras, and Antequera). American Journal of Tropical Medicine and Hygiene 34:956–965
    [Google Scholar]
  5. Centers for Disease Control 1973; Venezuelan equine encephalitis – United States, 1972. Morbidity and Mortality Weekly Report 22:126–131
    [Google Scholar]
  6. France J. K., Wyrick B. C., Trent D. W. 1979; Biochemical and antigenic comparisons of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains. Journal of General Virology 44:725–740
    [Google Scholar]
  7. Franck P. T., Johnson K. M. 1971; An outbreak of Venezuelan equine encephalomyelitis in Central America. Evidence for exogenous source of a virulent virus subtype. American Journal of Epidemiology 94:487–495
    [Google Scholar]
  8. Gilyard R. T. 1945; A clinical study of Venezuelan virus equine encephalomyelitis in Trinidad, B.W.I. Journal of the American Veterinary Medical Association 106:267–277
    [Google Scholar]
  9. Groot H. 1972; The health and economic impact of Venezuelan equine encephalitis (VEE). In Venezuelan Encephalitis pp. 7–16 Science Publication no. 243 Washington, D.C.: Pan American Health Organization;
    [Google Scholar]
  10. Johnson B. J. B., Kinney R. M., Kost C. L., Trent D. W. 1986; Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus. Journal of General Virology 67:1951–1960
    [Google Scholar]
  11. Johnson K. M., Martin D. H. 1974; Venezuelan equine encephalitis. Advances in Veterinary Science and Comparative Medicine 18:79–116
    [Google Scholar]
  12. Kinney R. M., Trent D. W. 1982; Conservation of tryptic peptides in the structural proteins of viruses in the Venezuelan encephalitis complex. Virology 121:345–362
    [Google Scholar]
  13. Kinney R. M., Trent D. W., France J. K. 1983; Comparative immunological and biochemical analyses of viruses in the Venezuelan equine encephalitis virus complex. Journal of General Virology 64:135–147
    [Google Scholar]
  14. Kinney R. M., Johnson B. J. B., Brown V. L., Trent D. W. 1986; Nucleotide sequence of the 26S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequences of the encoded structural proteins. Virology 152:400–413
    [Google Scholar]
  15. Kinney R. M., Johnson B. J. B., Welch J. B., Tsuchiya K. R., Trent D. W. 1989; The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 170:19–30
    [Google Scholar]
  16. Kubes V., Rios F. A. 1939; The causative agent of infectious equine encephalomyelitis in Venezuela. Science 90:20–21
    [Google Scholar]
  17. McKinney R. W. 1972; Inactivated and live VEE vaccines – a review. In Venezuelan Encephalitis pp. 369–384 Science Publication no. 243 Washington, D,. C.: Pan American Health Organization;
    [Google Scholar]
  18. Mecham J. O., Trent D. W. 1982; Glycosylation patterns of the envelope glycoproteins of an equine-virulent Venezuelan equine encephalitis virus and its vaccine derivative. Journal of General Virology 63:121–129
    [Google Scholar]
  19. Monath T. P., Cropp C. B., Short W. F., Bowen R. A., Kinney R. M., Roehrig J. T., Trent D. W. 1992; Recombinant vaccinia-Venezuelan equine encephalomyelitis (VEE) vaccine protects nonhuman primates against parenteral and intranasal challenge with virulent VEE virus. Vaccine Research 1:55–68
    [Google Scholar]
  20. Randall R., Mills J. W. 1944; Fatal encephalitis in man due to the Venezuelan virus of equine encephalomyelitis in Trinidad. Science 99:225–226
    [Google Scholar]
  21. Randall R., Maurer F. D., Smadel J. E. 1949; Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine. Journal of Immunology 63:313–318
    [Google Scholar]
  22. Sabattini M. S., Monath T. P., Mitchell C. J., Daffner J. F., Bowen G. S., Pauli R., Contigiani M. S. 1985; Arbovirus investigations in Argentina, 1977–1980. I. Historical aspects and description of study sites. American Journal of Tropical Medicine and Hygiene 34:937–944
    [Google Scholar]
  23. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
  24. Sanger F., Coulson A. R., Barrell B. G., Smith A. J. H., Roe B. A. 1980; Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. Journal of Molecular Biology 143:161–178
    [Google Scholar]
  25. Smith D. G., Mamav H. K., Marshall R. G., Wagner J. C. 1956; Venezuelan equine encephalomyelitis. Laboratory aspects of fourteen human cases following vaccination and attempts to isolate the virus from the vaccine. American Journal of Hygiene 63:150–164
    [Google Scholar]
  26. Sotomayer C. G. 1946; A study of the virus of equine encephalomyelitis in Ecuador. Journal of the American Veterinary Medical Association 109:478–480
    [Google Scholar]
  27. Spertzel R. O., Kahn D. E. 1971; Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in equidae. Journal of the American Veterinary Medical Association 159:731–738
    [Google Scholar]
  28. Spertzel R. O., McKinney R. W. 1972; Venezuelan equine encephalomyelitis in Central America and Mexico. Military Medicine 137:441–445
    [Google Scholar]
  29. Strauss E. G., Strauss J. H. 1986; Structure and replication of the alphavirus genome. In The Togaviridae and Flaviviridae pp. 35–90 Edited by Schlesinger S., Schlesinger M. New York & London: Plenum Press;
    [Google Scholar]
  30. Sudia W. D., Newhouse V. F. 1971; Venezuelan equine encephalitis in Texas, 1971. Mosquito News 31:350–351
    [Google Scholar]
  31. Sudia W. D., Newhouse V. F. 1975; Epidemic Venezuelan equine encephalitis in North America: a summary of virus-vector-host relationships. American Journal of Epidemiology 101:1–13
    [Google Scholar]
  32. Sutton L. S., Brooke C. C. 1954; Venezuelan equine encephalomyelitis due to vaccination in man. Journal of the American Medical Association 155:1473–1476
    [Google Scholar]
  33. Trent D. W., Clewley J. P., France J. K., Bishop D. H. L. 1979; Immunochemical and oligonucleotide fingerprint analyses of Venezuelan equine encephalomyelitis complex viruses. Journal of General Virology 43:365–381
    [Google Scholar]
  34. Walton T. E., Johnson K. M. 1972; Epizootiology of Venezuelan equine encephalomyelitis in the Americas. Journal of the American Veterinary Medical Association 161:1509–1515
    [Google Scholar]
  35. Walton T. E., Brantigam F. E., Ferrer J. A., Johnson K. M. 1972; Epizootic Venezuelan equine encephalomyelitis in Centred America. Disease pattern and vaccine evaluation in Nicaragua, 1969–1970. American Journal of Epidemiology 95:247–254
    [Google Scholar]
  36. Young N. A. 1972; Origin of epidemics of Venezuelan equine encephalitis. Journal of Infectious Diseases 25:565–567
    [Google Scholar]
  37. Young N. A., Johnson K. M. 1969; Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiological significance. American Journal of Epidemiology 89:286–307
    [Google Scholar]
  38. Zehmer R. B., Dean P. B., Sudia W. D., Calisher C. H., Sather G. E., Parker R. L. 1974; Venezuelan equine encephalitis epidemic in Texas, 1971. Health Services Reports 89:278–282
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-12-3301
Loading
/content/journal/jgv/10.1099/0022-1317-73-12-3301
Loading

Data & Media loading...

Most cited Most Cited RSS feed